Pregnancy
Conditions
Interventions
Tranexamic acid 1 gm+ NSS 10 ml i.v.,NSS 30 ml i.v.
Active Comparator Drug,Placebo Comparator No treatment
Sponsors
None
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age >18 years Normal delivery Gestational age > 36 week Singleton
Exclusion criteria
Exclusion criteria: -History of venous thrombosis (deep vein thrombosis and or pulmonary embolism) or arterial thrombosis (angina pectoris, myocardial infarction, stroke) -History of epilepsy or seizure -Underlying disease cardiovascular,renal,liver disorders,Autoimmune disease -Abnormal placenta : Placenta previa, Abnormally invasive placenta (placenta accreta/increta/percreta), Abruptio placenta 
 -Preeclampsia with or without severe feature, Eclampsia,HELLP syndrome 
 -Multiple pregnancy -DFIU -Vaccuum extraction, Forcep extraction 
 -History of maternal use LMWH or anti platelet agents 1 week before delivery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postpartum blood loss 2 hour after postpartum randomized controlled trial,Postpartum blood loss 2 hour after postpartum randomized controlled trial | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Postpartum hemorrhage 2 hr after Postpartum randomized controlled trial,Postpartum hematocrit change 2 hr after Postpartum randomized controlled trial,Use other uterotonic agent 2 hr after Postpartum randomized controlled trial,Thromboembolic even and side effect 2 hr after Postpartum randomized controlled trial | — |
Countries
Thailand
Contacts
Public ContactAnuchat Sujita
Udonthani hospital
Outcome results
None listed